Acetylsalicylic acid Completed Phase 3 Trials for Cerebral Infarctions Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00129805Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)
NCT00202020Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke